33295-47-5Relevant articles and documents
BENZOINDAZOLONE COMPOUND, AND INTERMEDIATE THEREOF
-
, (2022/01/12)
The present invention relates to a benzoindazolone compound, or a pharmaceutically acceptable salt, hydrate, solvate, enantiomer, diasteromer, tautomer or prodrug thereof; and an intermediate thereof. A compound according to the present invention is used as a substrate for NQO1 to facilitate a redox reaction of NQO1, and thus is expected to be developable as a medicine for preventing or treating inflammatory diseases.
1-Methoxyisobenzofuran: Formation from 1,3-Dihydro-1,1-dimethoxyisobenzofuran
Makhlouf, Mansour A.,Rickborn, Bruce
, p. 2734 - 2739 (2007/10/02)
1-Methoxyisobenzofuran is formed by treatment of 1,3-dihydro-1,1-dimethoxyisobenzofuran with either a trace of acetic acid in refluxing toluene or with LDA at 70 deg C.The requirements to obtain Diels-Alder adducts under both sets of conditions are examined, and various products are characterized.